Joshua Sabari, MD

Author

Latest Videos
FDA Approval of Zongertinib in HER2-Mutated NSCLC

Video

FDA Approval of Zongertinib in HER2-Mutated NSCLC

Joshua Sabari, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

New Insights From the MARIPOSA Trial: Amivantamab Plus Lazertinib for EGFR-Mutated NSCLC

Video

New Insights From the MARIPOSA Trial: Amivantamab Plus Lazertinib for EGFR-Mutated NSCLC

Helena Yu, MD | Joshua Sabari, MD

Targeted Therapies in EGFR-Mutated NSCLC: Managing Treatment-Related AEs

Video

Targeted Therapies in EGFR-Mutated NSCLC: Managing Treatment-Related AEs

Estelamari Rodriguez, MD, MPH | Helena Yu, MD | Joshua Sabari, MD